Brevan Howard Capital Management’s Henry Schein HSIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.52M Buy
+61,381
New +$4.74M 0.04% 268
2025
Q4
Sell
-43,224
Closed -$2.87M 2020
2025
Q3
$2.87M Sell
43,224
-12,453
-22% -$862K 0.01% 423
2025
Q2
$4.07M Buy
+55,677
New +$3.83M 0.02% 451
2024
Q3
Sell
-6,508
Closed -$417K 1271
2024
Q2
$417K Buy
6,508
+3,092
+91% +$218K ﹤0.01% 671
2024
Q1
$258K Sell
3,416
-7,279
-68% -$546K ﹤0.01% 714
2023
Q4
$810K Buy
+10,695
New +$748K 0.01% 300

Other funds holding HSIC

Brevan Howard Capital Management's HSIC Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Henry Schein (HSIC) in Q1 2026: 61,381 shares worth $4.52M. The stake represents 0.04% of the portfolio and ranks #268 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in HSIC as recently as Q3 2025.

Brevan Howard Capital Management first reported a position in HSIC in Q4 2023 and has held it in 6 quarters since. 557 funds tracked by Wall St. Rank hold HSIC as of Q1 2026.

  • Brevan Howard Capital Management held 61,381 shares of Henry Schein worth $4.52M as of Q1 2026.
  • Henry Schein was a new Brevan Howard Capital Management position in Q1 2026.
  • Henry Schein made up 0.04% of Brevan Howard Capital Management's portfolio in Q1 2026, its #268 holding.
  • Brevan Howard Capital Management first reported a position in Henry Schein in Q4 2023 and has held it in 6 quarters since.
  • 557 funds tracked by Wall St. Rank held Henry Schein as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.